Variable | Cases, n | PD-1+CD8+T (%) | PD-1+CD8+Tm (%) | PD-1+CD8+T/PD-1+CD4+T ratio | ||||||
---|---|---|---|---|---|---|---|---|---|---|
 ≥ 21.0, n |  < 21.0, n | P-value |  ≥ 64.3, n |  < 64.3, n | P-value |  ≥ 0.669, n |  < 0.669, n | P-value | ||
Total patients | 187 | 90 | 97 | Â | 81 | 106 | Â | 79 | 108 | Â |
Age, years | Â | Â | Â | 0.355 | Â | Â | 0.177 | Â | Â | 0.266 |
   ≥ 60 | 112 | 57 | 55 |  | 53 | 59 |  | 51 | 61 |  |
   < 60 | 75 | 33 | 42 |  | 28 | 47 |  | 28 | 47 |  |
Sex | Â | Â | Â | 0.916 | Â | Â | 0.896 | Â | Â | 0.953 |
 Male | 144 | 69 | 75 |  | 62 | 82 |  | 61 | 83 |  |
 Female | 43 | 21 | 22 |  | 19 | 24 |  | 18 | 25 |  |
Drinking history | Â | Â | Â | 0.332 | Â | Â | 0.654 | Â | Â | 0.967 |
 Yes | 137 | 63 | 74 |  | 58 | 79 |  | 58 | 79 |  |
 No | 50 | 27 | 23 |  | 23 | 27 |  | 21 | 29 |  |
ECOG PS | Â | Â | Â | 0.093 | Â | Â | 0.068 | Â | Â | 0.058 |
 0–1 | 113 | 60 | 53 |  | 55 | 58 |  | 54 | 59 |  |
 2 | 74 | 30 | 44 |  | 26 | 48 |  | 25 | 49 |  |
Stage | Â | Â | Â | 0.495 | Â | Â | 0.376 | Â | Â | 0.017 |
 III | 137 | 68 | 69 |  | 62 | 75 |  | 65 | 72 |  |
 IV | 50 | 22 | 28 |  | 19 | 31 |  | 14 | 36 |  |
Differentiation | Â | Â | Â | 0.099 | Â | Â | 0.475 | Â | Â | 0.046 |
 Well or moderate | 124 | 65 | 59 |  | 56 | 68 |  | 46 | 78 |  |
 Poor | 63 | 25 | 38 |  | 25 | 38 |  | 33 | 30 |  |
Response |  |  |  |  < 0.001 |  |  |  < 0.001 |  |  |  < 0.001 |
 R | 122 | 90 | 32 |  | 80 | 42 |  | 70 | 52 |  |
 NonR | 65 | 0 | 65 |  | 1 | 64 |  | 9 | 56 |  |
PD-L1 CPS |  |  |  |  < 0.001 |  |  |  < 0.001 |  |  |  < 0.001 |
   ≥ 5 | 104 | 81 | 23 |  | 78 | 26 |  | 65 | 39 |  |
   < 5 | 83 | 9 | 74 |  | 3 | 80 |  | 14 | 69 |  |